Current status of gene therapy for breast cancer: progress and challenges

References

• Official Journal of the European UnionL 159: Commission Directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2003:159:0046:0094:en:PDFAccessed October 15, 2014
   Google Scholar
• KanOGriffithsLBabanDDirect retroviral delivery of human cytochrome P450 2B6 for gene-directed enzyme prodrug therapy of cancerCancer Gene Ther20018747348211498768
   PubMed Web of Science ®Google Scholar
• BraybrookeJPSladeADeplanqueGPhase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanomaClin Cancer Res20051141512152015746054
   PubMed Web of Science ®Google Scholar
• GordonEMLevyJPReedRATargeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situInt J Oncol200833466567518813779
   PubMed Web of Science ®Google Scholar
• GordonEMHallFLNoteworthy clinical case studies in cancer gene therapy: tumor-targeted Rexin-G advances as an efficacious anti-cancer agentInt J Oncol20103661341135320428757
   PubMed Web of Science ®Google Scholar
• HartkopfADFehmTWallwienerDLauerUMOncolytic virotherapy of breast cancerGynecol Oncol2011123116417121764108
   PubMed Web of Science ®Google Scholar
• TakakuwaHGoshimaFNozawaNOncolytic viral therapy using a spontaneously generated herpes simplex virus type 1 variant for disseminated peritoneal tumor in immunocompetent miceArch Virol2003148481382512664303
   PubMed Web of Science ®Google Scholar
• TeshigaharaOGoshimaFTakaoKOncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10J Surg Oncol2004851424714696086
   PubMed Web of Science ®Google Scholar
• KimataHImaiTKikumoriTPilot study of oncolytic viral therapy using mutant herpes simplex virus (HF10) against recurrent metastatic breast cancerAnn Surg Oncol20061381078108416865590
   PubMed Web of Science ®Google Scholar
• SahinTTKasuyaHNomuraNImpact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancerCancer Gene Ther201219422923722193629
   PubMed Web of Science ®Google Scholar
• RussellSJFederspielMJPengKWRemission of disseminated cancer after systemic oncolytic virotherapyMayo Clin Proc201489792693324835528
   PubMed Web of Science ®Google Scholar
• HuJCCoffinRSDavisCJA phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factorClin Cancer Res200612226737674717121894
   PubMed Web of Science ®Google Scholar
• LiuBLRobinsonMHanZQICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour propertiesGene Ther200310429230312595888
   PubMed Web of Science ®Google Scholar
• GuffeyMBParkerJNLuckettWSJrEngineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumorsCancer Gene Ther2007141455616990846
   PubMed Web of Science ®Google Scholar
• PapanastassiouVRamplingRFraserMThe potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle studyGene Ther20029639840611960316
   PubMed Web of Science ®Google Scholar
• MacKieRMStewartBBrownSMIntralesional injection of herpes simplex virus 1716 in metastatic melanomaLancet2001357925552552611229673
   PubMed Web of Science ®Google Scholar
• CodyJJScaturroPCantorABYancey GillespieGParkerJNMarkertJMPreclinical evaluation of oncolytic deltagamma(1)34.5 herpes simplex virus expressing interleukin-12 for therapy of breast cancer brain metastasesInt J Breast Cancer2012201262869723346408
   PubMedGoogle Scholar
• ColomboMPTrinchieriGInterleukin-12 in anti-tumor immunity and immunotherapyCytokine Growth Factor Rev200213215516811900991
   PubMed Web of Science ®Google Scholar
• SieglGBiology and pathogenicity of autonomous parvovirusesBernsKIThe Parvoviruses1st edNew YorkSpringer US1984264297
   Google Scholar
• CornelisJJChenYQSpruytNSusceptibility of human cells to killing by the parvoviruses H-1 and minute virus of mice correlates with viral transcriptionJ Virol1990646253725442139892
   PubMed Web of Science ®Google Scholar
• SiebenMSchaferPDinsartCGallePRMoehlerMActivation of the human immune system via toll-like receptors by the oncolytic parvovirus H-1Int J Cancer2013132112548255623151948
   PubMed Web of Science ®Google Scholar
• MuharramGLe RhunELoisonIParvovirus H-1 induces cytopathic effects in breast carcinoma-derived culturesBreast Cancer Res Treat20101211233319565332
   PubMed Web of Science ®Google Scholar
• AngelovaALAprahamianMGrekovaSPImprovement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PVClin Cancer Res200915251151919147756
   PubMed Web of Science ®Google Scholar
• EnderlinMKleinmannEVStruyfSTNF-alpha and the IFN-gamma-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastomaCancer Gene Ther200916214916018670452
   PubMed Web of Science ®Google Scholar
• NormanKLCoffeyMCHirasawaKReovirus oncolysis of human breast cancerHum Gene Ther200213564165211916487
   PubMed Web of Science ®Google Scholar
• GollamudiRGhalibMHDesaiKKIntravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumorsInvest New Drugs201028564164919572105
   PubMed Web of Science ®Google Scholar
• VidalLPandhaHSYapTAA phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancerClin Cancer Res200814217127713718981012
   PubMed Web of Science ®Google Scholar
• HarringtonKJKarapanagiotouEMRoulstoneVTwo-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancersClin Cancer Res201016113067307720484020
   PubMed Web of Science ®Google Scholar
• NanniPGattaVMenottiLPreclinical therapy of disseminated HER-2(+) ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirusPLoS Pathog201391e100315523382683
   PubMed Web of Science ®Google Scholar
• CodyJJMarkertJMHurstDRHistone deacetylase inhibitors improve the replication of oncolytic herpes simplex virus in breast cancer cellsPLoS One201493e9291924651853
   PubMed Web of Science ®Google Scholar
• WaltherWSiegelRKobeltDNovel jet-injection technology for nonviral intratumoral gene transfer in patients with melanoma and breast cancerClin Cancer Res200814227545755319010873
   PubMed Web of Science ®Google Scholar
• ShibataMAItoYMorimotoJKusakabeKYoshinakaROtsukiYIn vivo electrogene transfer of interleukin-12 inhibits tumor growth and lymph node and lung metastases in mouse mammary carcinomasJ Gene Med20068333535216345101
   PubMed Web of Science ®Google Scholar
• MiyataKNishiyamaNKataokaKRational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial virusesChem Soc Rev20124172562257422105545
   PubMed Web of Science ®Google Scholar
• YooGHHungMCLopez-BeresteinGPhase I trial of intratu-moral liposome E1A gene therapy in patients with recurrent breast and head and neck cancerClin Cancer Res2001751237124511350889
   PubMed Web of Science ®Google Scholar
• HortobagyiGNUenoNTXiaWCationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trialJ Clin Oncol200119143422343311454891
   PubMed Web of Science ®Google Scholar
• GribbenJGRyanDPBoyajianRUnexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapyClin Cancer Res200511124430443615958627
   PubMed Web of Science ®Google Scholar
• McCruddenCMcCarthyHCancer gene therapy – key biological concepts in the design of multifunctional non-viral delivery systemsMolinaFMCancer Gene Therapy1st edRijeka, CroatiaInTech2013213235
   Google Scholar
• RobsonTHirstDGTranscriptional targeting in cancer gene therapyJ Biomed Biotechnol20032003211013712721516
   PubMedGoogle Scholar
• BianchiniGGianniLThe immune system and response to HER2-targeted treatment in breast cancerLancet Oncol2014152e58e6824480556
   PubMed Web of Science ®Google Scholar
• McCarthyHOCoulterJAWorthingtonJRobsonTHirstDGHuman osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancerJ Gene Med20079651152017471586
   PubMed Web of Science ®Google Scholar
• CoulterJAPageNLWorthingtonJRobsonTHirstDGMcCarthyHOTranscriptional regulation of inducible nitric oxide synthase gene therapy: targeting early stage and advanced prostate cancerJ Gene Med201012975576520821746
   PubMed Web of Science ®Google Scholar
• PandhaHSMartinLARiggAGenetic prodrug activation therapy for breast cancer: a phase I clinical trial of erbB-2-directed suicide gene expressionJ Clin Oncol19991772180218910561274
   PubMed Web of Science ®Google Scholar
• GargHSalcedoRTrinchieriGBlumenthalRImproved nonviral cancer suicide gene therapy using survivin promoter-driven mutant BaxCancer Gene Ther201017315516319816523
   PubMed Web of Science ®Google Scholar
• SadeqzadehERahbarizadehFAhmadvandDRasaeeMJParhamifarLMoghimiSMCombined MUC1-specific nanobody-tagged PEG-polyethylenimine polyplex targeting and transcriptional targeting of tBid transgene for directed killing of MUC1 over-expressing tumour cellsJ Control Release20111561859121704663
   PubMed Web of Science ®Google Scholar
• YunHJChoYHMoonYTranscriptional targeting of gene expression in breast cancer by the promoters of protein regulator of cytokinesis 1 and ribonuclease reductase 2Exp Mol Med200840334535318587273
   PubMed Web of Science ®Google Scholar
• YanCWen-ChaoLHong-YanQRuiZWei-LinJHuaHA new targeting approach for breast cancer gene therapy using the human fatty acid synthase promoterActa Oncol200746677378117653900
   PubMed Web of Science ®Google Scholar
• AndersonLMKrotzSWeitzmanSAThimmapayaBBreast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approachCancer Gene Ther20007684585210880014
   PubMed Web of Science ®Google Scholar
• RaoDDVorhiesJSSenzerNNemunaitisJsiRNA vs shRNA: similarities and differencesAdv Drug Deliv Rev200961974675919389436
   PubMed Web of Science ®Google Scholar
• YangFHuangWLiYAnti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticlesBiomaterials201334225689569923632321
   PubMed Web of Science ®Google Scholar
• GaoYChenLZhangZChenYLiYReversal of multidrug resistance by reduction-sensitive linear cationic click polymer/iMDR1-pDNA complex nanoparticlesBiomaterials20113261738174721112086
   PubMed Web of Science ®Google Scholar
• WangYGaoSYeWHYoonHSYangYYCo-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymerNat Mater200651079179616998471
   PubMed Web of Science ®Google Scholar
• Janat-AmsburyMMYockmanJWLeeMCombination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer modelMol Ther20049682983615194049
   PubMed Web of Science ®Google Scholar
• OkamotoAAsaiTKatoHAntibody-modified lipid nanoparticles for selective delivery of siRNA to tumors expressing membrane-anchored form of HB-EGFBiochem Biophys Res Commun2014449446046524853808
   PubMed Web of Science ®Google Scholar
• DingYWangYZhouJDirect cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesisBiomaterials201435257214722724875759
   PubMed Web of Science ®Google Scholar
• FengQYuMZWangJCSynergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticlesBiomaterials201435185028503824680191
   PubMed Web of Science ®Google Scholar
• RejeethCKannanSP53 gene therapy of human breast carcinoma: using a transferrin-modified silica nanoparticlesBreast Cancer Epub542014
   Web of Science ®Google Scholar
• MaoCQDuJZSunTMA biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapyBiomaterials201132113124313321277018
   PubMed Web of Science ®Google Scholar
• Medina-KauweLKMaguireMKasaharaNKedesLNonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteinsGene Ther20018231753176111803394
   PubMed Web of Science ®Google Scholar
• MangipudiSSCanineBFWangYHatefiADevelopment of a genetically engineered biomimetic vector for targeted gene transfer to breast cancer cellsMol Pharm2009641100110919419197
   PubMed Web of Science ®Google Scholar
• McCarthyHOZholobenkoAVWangYEvaluation of a multifunctional nanocarrier for targeted breast cancer iNOS gene therapyInt J Pharm20114051–219620221134429
   PubMed Web of Science ®Google Scholar
• JeyarajanSXavierJRaoNMGopalVPlasmid DNA delivery into MDA-MB-453 cells mediated by recombinant Her-NLS fusion proteinInt J Nanomedicine2010572573321042418
   PubMed Web of Science ®Google Scholar
• SoltaniFSankianMHatefiARamezaniMDevelopment of a novel histone H1-based recombinant fusion peptide for targeted non-viral gene deliveryInt J Pharm20134411–230731523200954
   PubMed Web of Science ®Google Scholar
• DouSYaoYDYangXZAnti-Her2 single-chain antibody mediated DNMTs-siRNA delivery for targeted breast cancer therapyJ Control Release2012161387588322762887
   PubMed Web of Science ®Google Scholar
• GovindarajanSSivakumarJGarimidiPTargeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugateBiomaterials20123382570258222192536
   PubMed Web of Science ®Google Scholar
• TangDCDeVitMJohnstonSAGenetic immunization is a simple method for eliciting an immune responseNature199235663651521541545867
   PubMed Web of Science ®Google Scholar
• UlmerJBFuTMDeckRRProtective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNAJ Virol1998727564856539621023
   PubMed Web of Science ®Google Scholar
• GrosenbaughDALeardATBergmanPJSafety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumorAm J Vet Res201172121631163822126691
   PubMed Web of Science ®Google Scholar
• SlamonDEiermannWRobertNAdjuvant trastuzumab in HER2-positive breast cancerN Engl J Med2011365141273128321991949
   PubMed Web of Science ®Google Scholar
• ChungMALuoYO’DonnellMDevelopment and preclinical evaluation of a Bacillus Calmette-Guérin-MUC1-based novel breast cancer vaccineCancer Res20036361280128712649188
   PubMed Web of Science ®Google Scholar
• HodgeJWCarcinoembryonic antigen as a target for cancer vaccinesCancer Immunol Immunother19964331271349001565
   PubMed Web of Science ®Google Scholar
• WatsonMADintzisSDarrowCMMammaglobin expression in primary, metastatic, and occult breast cancerCancer Res199959133028303110397237
   PubMed Web of Science ®Google Scholar
• BednarekAKSahinABrennerAJJohnstonDAAldazCMAnalysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stageClin Cancer Res19973111169815531
   PubMed Web of Science ®Google Scholar
• De GiovanniCNicolettiGQuaglinoEVaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2Breast Cancer Res2014161R1024451168
   PubMed Web of Science ®Google Scholar
• NorellHPoschkeICharoJVaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trialJ Transl Med201085320529245
   PubMed Web of Science ®Google Scholar
• NarayananKJaramilloABenshoffNDResponse of established human breast tumors to vaccination with mammaglobin-A cDNAJ Natl Cancer Inst200496181388139615367572
   PubMedGoogle Scholar
• TiriveedhiVFlemingTPGoedegebuurePSMammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cellsBreast Cancer Res Treat2013138110911822678162
   PubMed Web of Science ®Google Scholar
• EndmannAOswaldDRiedeOCombination of MIDGE-Th1 DNA vaccines with the cationic lipid SAINT-18: studies on formulation, biodistribution and vector clearanceVaccine201432273460346724681271
   PubMed Web of Science ®Google Scholar
• MairhoferJCserjan-PuschmannMStriednerGNobauerKRazzazi-FazeliEGrabherrRMarker-free plasmids for gene therapeutic applications – lack of antibiotic resistance gene substantially improves the manufacturing processJ Biotechnol2010146313013720138928
   PubMed Web of Science ®Google Scholar
• WaltersAAKinnearEShattockRJComparative analysis of enzymatically produced novel linear DNA constructs with plasmids for use as DNA vaccinesGene Ther201421764565224830436
   PubMed Web of Science ®Google Scholar
• CanineBFWangYHatefiABiosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cellsJ Control Release2009138318819619379785
   PubMed Web of Science ®Google Scholar